Anna D. Barker - Concepedia

Author

Anna D. Barker

Also Known As

A BARKER, A Barker, A D Barker, A. Barker, A. D. Barker, A.D. Barker, Anna Barker, Anna D Barker, Anna D. Barker, Barker, A

Publications

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Arizona State University The Ohio State University Stanford University

About

Anna D. Barker is an author at National Cancer Institute specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	791
2	Engineering	4	4	277
3	Public Health	1	1	69
4	Allergy	1	1	16
5	Biomedical Engineering	1	1	12

Anna D. Barker

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
International network of cancer genome projects Thomas J. Hudson, Warwick P. Anderson, Anna D. Barker, Nature	2010	2.4K
Chemotherapy of human tumor xenografts in genetically athymic mice. Artemio A. Ovejera, David P. Houchens, Anna D. Barker Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) Human BreastTumor BiologyTumor XenograftsHuman Tumor XenograftsGrowth Rate	1978	196
Mapping the Cancer Genome Francis S. Collins, Anna D. Barker Scientific American Functional GenomicsTumor HeterogeneityCancer GenomicsCancer GeneticsSystems Biology	2007	193
Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Francis S. Collins, Anna D. Barker PubMed OncologyEngineeringTumor HeterogeneityMedicineCancer Genomics	2007	177
Recent Advances from the National Cancer Institute Alliance for Nanotechnology in Cancer Dorothy Farrell, Joe Alper, Krzystof Ptak, ACS Nano	2010	76
AACR Cancer Progress Report 2013 Charles L. Sawyers, Cory Abate‐Shen, Kenneth C. Anderson, Clinical Cancer Research Cancer ManagementPathologyCancer EducationTumor BiologyTranslational Medicine	2013	69
Opening Up to Precompetitive Collaboration Jill S. Altshuler, Erin P. Balogh, Anna D. Barker, Science Translational Medicine EngineeringDevelopment EfficiencyTranslational AdvanceCommunicationNontraditional Research Collaborations	2010	59
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Amr E. Abbas, Fatima Abbas, The Lancet Diabetes & Endocrinology	2023	34
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial Saul N. Faust, Richard Haynes, Christine E. Jones, The Lancet Child & Adolescent Health	2024	31
The NCI Alliance for Nanotechnology in Cancer: achievement and path forward Krzysztof Ptak, Dorothy Farrell, Nicholas J. Panaro, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology NanoparticlesEngineeringCancer NanotechnologyCancer OutcomesTumor Biology	2010	29

Page 1